TCA cycle metabolic compromise due to an aberrant S-nitrosoproteome in HIV-associated neurocognitive disorder with methamphetamine use

J Neurovirol. 2021 Jun;27(3):367-378. doi: 10.1007/s13365-021-00970-4. Epub 2021 Apr 19.

Abstract

In the brain, both HIV-1 and methamphetamine (meth) use result in increases in oxidative and nitrosative stress. This redox stress is thought to contribute to the pathogenesis of HIV-associated neurocognitive disorder (HAND) and further worsening cognitive activity in the setting of drug abuse. One consequence of such redox stress is aberrant protein S-nitrosylation, derived from nitric oxide, which may disrupt normal protein activity. Here, we report an improved, mass spectrometry-based technique to assess S-nitrosylated protein in human postmortem brains using selective enrichment of S-nitrosocysteine residues with an organomercury resin. The data show increasing S-nitrosylation of tricarboxylic acid (TCA) enzymes in the setting of HAND and HAND/meth use compared with HIV+ control brains without CNS pathology. The consequence is systematic inhibition of multiple TCA cycle enzymes, resulting in energy collapse that can contribute to the neuronal and synaptic damage observed in HAND and meth use.

Keywords: HIV-1; Methamphetamine; Mitochondrial dysfunction; Protein S-nitrosylation; TCA cycle.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Autopsy
  • Biological Specimen Banks
  • Brain / drug effects
  • Brain / enzymology
  • Brain / pathology
  • Citric Acid Cycle / drug effects*
  • Citric Acid Cycle / genetics
  • Cognitive Dysfunction / complications
  • Cognitive Dysfunction / metabolism*
  • Cognitive Dysfunction / pathology
  • Cognitive Dysfunction / virology
  • Cysteine / analogs & derivatives
  • Cysteine / metabolism
  • HIV Infections / complications
  • HIV Infections / metabolism*
  • HIV Infections / pathology
  • HIV Infections / virology
  • HIV-1 / growth & development
  • HIV-1 / pathogenicity
  • Humans
  • Male
  • Methamphetamine / adverse effects*
  • Middle Aged
  • Mitochondria / drug effects
  • Mitochondria / enzymology
  • Mitochondria / pathology
  • Neurons / drug effects
  • Neurons / enzymology
  • Neurons / pathology
  • Nitric Oxide / metabolism
  • Protein Processing, Post-Translational*
  • S-Nitrosothiols / metabolism
  • Substance-Related Disorders / complications
  • Substance-Related Disorders / metabolism*
  • Substance-Related Disorders / pathology
  • Substance-Related Disorders / virology
  • Synapses / drug effects
  • Synapses / pathology

Substances

  • S-Nitrosothiols
  • Nitric Oxide
  • Methamphetamine
  • S-nitrosocysteine
  • Cysteine